Eleftheria Kodosaki

Experts / Eleftheria Kodosaki

Eleftheria Kodosaki

Research Associate in Neuroimmunology, Cardiff University

BSc (hons/1st) in Biology (National and Kapodistrian University of Athens, Greece), MSc in cognitive neuroscience (Aston University, UK), and PhD in neuroimmunology (Cardiff Metropolitan University, UK).Interested in the biology of neuroinflammation and neurodegeneration, and especially in how certain factors can push an inflamed brain towards neurological or psychiatric disorders.In the past I have investigated the changes of certain immune system biomarkers which are observed in patients with Multiple Sclerosis and Covid-19, while currently my focus has shifted to the immune basis of psychosis.

New Alzheimer’s drug: what you need to know about donanemab’s promising trial results

American pharmaceutical company Eli Lilly announced last week that it had seen

New Alzheimer’s drug: what you need to know about donanemab’s promising trial results

American pharmaceutical company Eli Lilly announced last week that it had seen

By Eleftheria Kodosaki

Clinical Articles

Evidence-based medicine